Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/9068
DC FieldValueLanguage
dc.contributor.authorSpyropoulos, Alex Cen_US
dc.contributor.authorAgeno, Walteren_US
dc.contributor.authorAlbers, Gregory Wen_US
dc.contributor.authorElliott, C Gregoryen_US
dc.contributor.authorHalperin, Jonathan Len_US
dc.contributor.authorHiatt, William Ren_US
dc.contributor.authorMaynard, Gregory Aen_US
dc.contributor.authorSteg, P Gabrielen_US
dc.contributor.authorWeitz, Jeffrey Ien_US
dc.contributor.authorSuh, Eunyoungen_US
dc.contributor.authorSpiro, Theodore Een_US
dc.contributor.authorBarnathan, Elliot Sen_US
dc.contributor.authorRaskob, Gary Een_US
dc.contributor.authorMARINER Investigators*en_US
dc.contributor.authorKuzmanovska, Biljanaen_US
dc.date.accessioned2020-09-18T09:42:55Z-
dc.date.available2020-09-18T09:42:55Z-
dc.date.issued2018-09-20-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/9068-
dc.description.abstractPatients who are hospitalized for medical illness remain at risk for venous thromboembolism after discharge, but the role of extended thromboprophylaxis in the treatment of such patients is a subject of controversy.en_US
dc.language.isoenen_US
dc.relation.ispartofThe New England journal of medicineen_US
dc.titleRivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illnessen_US
dc.typeArticleen_US
dc.identifier.doi10.1056/NEJMoa1805090-
dc.identifier.volume379-
dc.identifier.issue12-
item.fulltextNo Fulltext-
item.grantfulltextnone-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Journal Articles
Show simple item record

Page view(s)

27
checked on Jul 25, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.